Malm J, Kristensen B, Ekstedt J, Wester P
Department of Neurology, University Hospital of Northern Sweden, Umeå.
J Neurol Neurosurg Psychiatry. 1994 Sep;57(9):1026-33. doi: 10.1136/jnnp.57.9.1026.
Concentration gradients of homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA), and 3-methoxy-4-hydroxyphenylglycol (MHPG), were assessed in 762 successive CSF fractions (2 ml lumbar CSF) from 15 patients with the adult hydrocephalus syndrome (AHS) and 11 patients with hydrocephalus of other causes (mixed group). A mean volume of 49.6 (SD 11.8) ml CSF was removed in the AHS group and 56.4 (10.2) ml in the mixed group. The CSF was collected with a specially designed carousel fraction collector and the corresponding CSF dynamics were continuously registered by a constant pressure CSF infusion method. Pronounced gradients in CSF HVA and CSF 5-HIAA were seen in both patient groups in the first 25 ml of CSF removed. The concentration curves levelled off, despite the removal of larger amounts of CSF and stabilised at about twice the initial concentrations. This phenomenon has not been described before. Concentrations of HVA and 5-HIAA in the first CSF fraction correlated strongly with concentrations in fractions up to about 40 ml. A positive correlation between the first fraction of CSF HVA and CSF 5-HIAA concentrations and CSF outflow conductance was found in the AHS group. There was no gradient in MHPG. It is suggested that the rostrocaudal gradients in CSF HVA and 5-HIAA may be explained by a downward flow of CSF along the spinal cord with absorption of metabolites occurring during passage. Mixing of CSF from different CSF compartments, extraventricular production sites of CSF, clearance of metabolites to venous blood or extracellular fluid, and CSF outflow conductance are probably important determinants of the plateau phase in patients with hydrocephalus. It is concluded that lumbar CSF does not exclusively reflect the concentrations of HVA, 5-HIAA, or MHPG in the ventricles. It should be noted that these results obtained in patients with hydrocephalus may not be applicable to other groups of patients or normal subjects.
在来自15例成人脑积水综合征(AHS)患者和11例其他原因脑积水患者(混合组)的762份连续脑脊液样本(2ml腰段脑脊液)中,评估了高香草酸(HVA)、5-羟吲哚乙酸(5-HIAA)和3-甲氧基-4-羟基苯乙二醇(MHPG)的浓度梯度。AHS组平均抽取脑脊液49.6(标准差11.8)ml,混合组为56.4(10.2)ml。脑脊液通过专门设计的转盘式收集器收集,相应的脑脊液动力学通过恒压脑脊液输注法持续记录。在抽取的前25ml脑脊液中,两组患者的脑脊液HVA和脑脊液5-HIAA均出现明显梯度。尽管抽取了大量脑脊液,但浓度曲线趋于平稳,并稳定在初始浓度的两倍左右。这种现象以前尚未有过描述。脑脊液第一份样本中HVA和5-HIAA的浓度与直至约40ml样本中的浓度密切相关。在AHS组中,脑脊液HVA和脑脊液5-HIAA浓度的第一份样本与脑脊液流出传导率呈正相关。MHPG没有梯度。提示脑脊液HVA和5-HIAA的头尾梯度可能是由于脑脊液沿脊髓向下流动并在通过过程中发生代谢产物吸收所致。来自不同脑脊液腔室的脑脊液混合、脑脊液的脑室外产生部位、代谢产物向静脉血或细胞外液的清除以及脑脊液流出传导率可能是脑积水患者平台期的重要决定因素。得出的结论是,腰段脑脊液并不能完全反映脑室中HVA、5-HIAA或MHPG的浓度。应当指出,在脑积水患者中获得的这些结果可能不适用于其他患者群体或正常受试者。